{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:09:48Z","timestamp":1791328188875,"version":"4.3.1"},"reference-count":35,"publisher":"American Society for Microbiology","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin. Vaccine Immunol."],"published-print":{"date-parts":[[2015,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Uveitis is a potentially blinding inflammatory disease. Thirty to 50% of uveitis cases are considered idiopathic. The present study sought to determine the intraocular cytokine patterns in the different etiological types of uveitis in order to better understand their immunological regulation and to determine whether the cytokine pattern may be a useful diagnostic tool. From a multicenter institutional prospective study, the clinical and biological data from patients with uveitis of various etiologies, determined after a complete workup, were compared with those from a control group of cataract patients. A multiplex assay was used to assess the profiles of 27 cytokines and chemokines in aqueous humor samples from these patients. In total, 62 patients with infectious or noninfectious uveitis and 88 controls were included. After a complete workup, the cause of uveitis remained unknown in 25 patients (40% idiopathic uveitis). Interleukin 1\u03b2 (IL-1\u03b2) levels were markedly increased in viral uveitis, as were IL-10 levels, whereas IL-17A levels were augmented in toxoplasmic uveitis. Based on the cytokine pattern, the patients were reassigned to specific groups. At the end of the study, the diagnosis of idiopathic uveitis was still valid in only 11 patients (18%). The observation that some markers are specific to certain diseases enables a better understanding of the disease pathogenesis and paves the way for new diagnostic methods aimed to identify inflammatory markers, which may perhaps be targeted by therapy.<\/jats:p>","DOI":"10.1128\/cvi.00423-14","type":"journal-article","created":{"date-parts":[[2014,11,7]],"date-time":"2014-11-07T08:03:16Z","timestamp":1415347396000},"page":"72-78","source":"Crossref","is-referenced-by-count":32,"title":["Intraocular Levels of Interleukin 17A (IL-17A) and IL-10 as Respective Determinant Markers of Toxoplasmosis and Viral Uveitis"],"prefix":"10.1128","volume":"22","author":[{"given":"Arnaud","family":"Sauer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odile","family":"Villard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Creuzot-Garcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Chiquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul","family":"Berrod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude","family":"Speeg-Schatz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tristan","family":"Bourcier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ermanno","family":"Candolfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","published-online":{"date-parts":[[2014,11,5]]},"reference":[{"key":"key20180919073754_B1","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/00005792-200107000-00005","article-title":"Chronic severe uveitis: etiology and visual outcome in 927 patients from a single center","volume":"80","year":"2001","journal-title":"Medicine (Baltimore)"},{"key":"key20180919073754_B2","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.preteyeres.2011.06.005","article-title":"Understanding uveitis: the impact of research on visual outcomes","volume":"30","year":"2011","journal-title":"Prog Retin Eye Res"},{"key":"key20180919073754_B3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1080\/09273940802491850","article-title":"Causes of uveitis at a referral center in Saudi Arabia","volume":"17","year":"2009","journal-title":"Ocul Immunol Inflamm"},{"key":"key20180919073754_B4","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/sj.eye.6702111","article-title":"Pattern of uveitis in a referral centre in Tunisia, North Africa","volume":"21","year":"2007","journal-title":"Eye (Lond)"},{"key":"key20180919073754_B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/IIO.0b013e3181d2cc6b","article-title":"The epidemiology of uveitis in developing countries","volume":"50","year":"2010","journal-title":"Int Ophthalmol Clin"},{"key":"key20180919073754_B6","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.4049\/jimmunol.168.5.2483","article-title":"Inflammatory mediators in uveitis: differential induction of cytokines and chemokines in Th1- versus Th2-mediated ocular inflammation","volume":"168","year":"2002","journal-title":"J Immunol"},{"key":"key20180919073754_B7","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1111\/j.1365-3024.2006.00874.x","article-title":"Ocular toxoplasmosis: in the storm of the eye","volume":"28","year":"2006","journal-title":"Parasite Immunol"},{"key":"key20180919073754_B8","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.immuni.2006.06.002","article-title":"Th17: an effector CD4 T cell lineage with regulatory T cell ties","volume":"24","year":"2006","journal-title":"Immunity"},{"key":"key20180919073754_B9","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/nm1585","article-title":"TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27\/STAT1","volume":"13","year":"2007","journal-title":"Nat Med"},{"key":"key20180919073754_B10","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0065-2776(08)00605-6","article-title":"Emergence of the Th17 pathway and its role in host defense","volume":"99","year":"2008","journal-title":"Adv Immunol"},{"key":"key20180919073754_B11","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1093\/infdis\/jis486","article-title":"Interleukin 17A as an effective target for anti-inflammatory and antiparasitic treatment of toxoplasmic uveitis","volume":"206","year":"2012","journal-title":"J Infect Dis"},{"key":"key20180919073754_B12","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1055\/s-2008-1027452","article-title":"The role of cytokines for the diagnosis of uveitis","volume":"225","year":"2008","journal-title":"Klin Monbl Augenheilkd"},{"key":"key20180919073754_B13","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1097\/ICU.0b013e32801094b5","article-title":"Inflammatory mediators of uveitis: cytokines and chemokines","volume":"17","year":"2006","journal-title":"Curr Opin Ophthalmol"},{"key":"key20180919073754_B14","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/nrrheum.2011.106","article-title":"Biologic therapies in non-rheumatic diseases: lessons for rheumatologists?","volume":"7","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"key20180919073754_B15","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3109\/09273948.2011.595872","article-title":"Diagnostic approach to ocular toxoplasmosis","volume":"19","year":"2011","journal-title":"Ocul Immunol Inflamm"},{"key":"key20180919073754_B16","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/eye.2011.363","article-title":"Viral causes of unexplained anterior uveitis in Thailand","volume":"26","year":"2012","journal-title":"Eye (Lond)"},{"key":"key20180919073754_B17","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1086\/597478","article-title":"Cytokine profiles in toxoplasmic and viral uveitis","volume":"199","year":"2009","journal-title":"J Infect Dis"},{"key":"key20180919073754_B18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.revmed.2010.07.020","article-title":"Clinical and etiological aspects of uveitis: a retrospective study of 121 patients referred to a tertiary centre of ophthalmology","volume":"32","year":"2011","journal-title":"Rev Med Interne"},{"key":"key20180919073754_B19","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/BF00917833","article-title":"Epidemiological characteristics of uveitis in Switzerland","volume":"18","year":"1994","journal-title":"Int Ophthalmol"},{"key":"key20180919073754_B20","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1097\/IIO.0b013e31822d6807","article-title":"Current diagnostic approaches to infectious anterior uveitis","volume":"51","year":"2011","journal-title":"Int Ophthalmol Clin"},{"key":"key20180919073754_B21","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3109\/09273948.2011.581407","article-title":"Review for disease of the year: differential diagnosis of ocular toxoplasmosis","volume":"19","year":"2011","journal-title":"Ocul Immunol Inflamm"},{"key":"key20180919073754_B22","first-page":"830","article-title":"Comparison of aqueous humor cytokine and chemokine levels in diabetic patients with and without retinopathy","volume":"18","year":"2012","journal-title":"Mol Vis"},{"key":"key20180919073754_B23","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1167\/iovs.05-0836","article-title":"Cytokine profile in aqueous humor and sera of patients with infectious or noninfectious uveitis","volume":"47","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key20180919073754_B24","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/S0008-4182(05)80087-0","article-title":"Cytokine profile in response to Cytomegalovirus associated with immune recovery syndrome after highly active antiretroviral therapy","volume":"40","year":"2005","journal-title":"Can J Ophthalmol"},{"key":"key20180919073754_B25","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1001\/archopht.118.6.768","article-title":"Aqueous and serum interferon gamma, interleukin (IL) 2, IL-4, and IL-10 in patients with uveitis","volume":"118","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"key20180919073754_B26","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3109\/09273949509069113","article-title":"Aqueous humor cytokine profile in patients with chronic uveitis","volume":"3","year":"1995","journal-title":"Ocul Immunol Inflamm"},{"key":"key20180919073754_B27","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.clim.2011.01.014","article-title":"Cytokine profiles in aqueous humor of patients with different clinical entities of endogenous uveitis","volume":"139","year":"2011","journal-title":"Clin Immunol"},{"key":"key20180919073754_B28","first-page":"2003","article-title":"Intraocular and serum cytokine profiles in patients with intermediate uveitis","volume":"17","year":"2011","journal-title":"Mol Vis"},{"key":"key20180919073754_B29","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ijpara.2013.09.007","article-title":"New clinical and experimental insights into Old World and neotropical ocular toxoplasmosis","volume":"44","year":"2014","journal-title":"Int J Parasitol"},{"key":"key20180919073754_B30","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1128\/IAI.73.1.617-621.2005","article-title":"Interleukin-17\/interleukin-17 receptor-mediated signaling is important for generation of an optimal polymorphonuclear response against Toxoplasma gondii infection","volume":"73","year":"2005","journal-title":"Infect Immun"},{"key":"key20180919073754_B31","doi-asserted-by":"publisher","first-page":"12504","DOI":"10.1128\/JVI.01111-07","article-title":"Herpes simplex virus remodels T-cell receptor signaling, resulting in p38-dependent selective synthesis of interleukin-10","volume":"81","year":"2007","journal-title":"J Virol"},{"key":"key20180919073754_B32","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1615\/CritRevImmunol.v28.i2.40","article-title":"Immune responses against persistent viral infections: possible avenues for immunotherapeutic interventions","volume":"28","year":"2008","journal-title":"Crit Rev Immunol"},{"key":"key20180919073754_B33","doi-asserted-by":"publisher","first-page":"3736","DOI":"10.1128\/JVI.02173-07","article-title":"Immunomodulatory properties of a viral homolog of human interleukin-10 expressed by human cytomegalovirus during the latent phase of infection","volume":"82","year":"2008","journal-title":"J Virol"},{"key":"key20180919073754_B34","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/S1473-3099(06)70577-1","article-title":"The two faces of interleukin 10 in human infectious diseases","volume":"6","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"key20180919073754_B35","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1006\/viro.2002.1716","article-title":"Epstein-Barr virus encoded interleukin-10 inhibits HLA-class I, ICAM-1, and B7 expression on human monocytes: implications for immune evasion by EBV","volume":"304","year":"2002","journal-title":"Virology"}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1128\/CVI.00423-14","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T20:51:17Z","timestamp":1627591877000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CVI.00423-14"}},"subtitle":[],"editor":[{"given":"C. J.","family":"Papasian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,11,5]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,12,30]]},"published-print":{"date-parts":[[2015,1]]}},"alternative-id":["10.1128\/CVI.00423-14"],"URL":"https:\/\/doi.org\/10.1128\/cvi.00423-14","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,5]]}}}